within Pharmacolibrary.Drugs.ATC.N;

model N06AB10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.01,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.0126,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008166666666666666,
    Tlag           = 9.6
  );

  annotation(Documentation(
    info ="<html><body><p>Escitalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant used for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder in adults. It is currently approved and widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers, both male and female.</p><h4>References</h4><ol><li>Niranjan Rao,The clinical pharmacokinetics of escitalopram.,Clinical pharmacokinetics,2007<a href='https://pubmed.ncbi.nlm.nih.gov/17375980/'>https://pubmed.ncbi.nlm.nih.gov/17375980/</a></li><li>Xin Liu, Gehang Ju, Wenyu Yang, Lulu Chen, Nuo Xu, Qingfeng He, Xiao Zhu, Dongsheng Ouyang,Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method.,Drug design, development and therapy,2023<a href='https://pubmed.ncbi.nlm.nih.gov/37789969/'>https://pubmed.ncbi.nlm.nih.gov/37789969/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06AB10;
